A change to a long-used vaccine is being considered by the CDC's vaccine advisers, which is expected to be controversial. The vaccine in question appears to be related to hepatitis B, with some reports indicating a vote has already been taken to overturn a decades-long policy on its use for infants, while others suggest a decision has been delayed. The issue has sparked tension and scrutiny, with some members of the advisory committee facing criticism and controversy.